Kevin A Sztam1, Enju Liu2, Karim P Manji3, Roland Kupka4, Rodrick Kisenge3, Said Aboud5, Wafaie W Fawzi6, Ronald J Bosch7, Christopher P Duggan8. 1. Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA. Electronic address: Kevin.Sztam@childrens.harvard.edu. 2. Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA. 3. Department of Pediatrics and Child Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. 4. Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA; Nutrition Section, UNICEF Headquarters, New York, NY. 5. Department of Microbiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. 6. Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA. 7. Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA. 8. Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA.
Abstract
OBJECTIVES: To identify risk factors, including maternal antiretroviral therapy (ART), for diarrhea in Tanzanian children exposed to HIV during the first 2 years of life. STUDY DESIGN: Using generalized estimating equations, we analyzed data from a cohort of 2387 Tanzanian children exposed to HIV from age 6 weeks to 2 years, as well as data from their mothers, to determine risk factors for diarrhea in children. Mothers recorded diarrhea in a diary and reported results at visits scheduled every four weeks. RESULTS: Body mass index was ≥18.5 in 95.6% of mothers. World Health Organization HIV stage was 1/2 for 1255 (87.8%) mothers. ART was received by 24.3% of mothers, most initiating ART during pregnancy. At baseline (6 weeks of age) 264 (11.3%) children were infected with HIV. In children whose mothers received ART, the relative risk of diarrhea in children was 0.79 (95% CI 0.68-0.92), after we adjusted for multiple factors, including child HIV status and exclusive breastfeeding duration. Exclusive breastfeeding (relative risk 0.67, 95% CI 0.56-0.80) also was protective. CONCLUSION: Our results provide additional support to increase ART coverage for all pregnant mothers, to control clinical HIV progression, reduce perinatal HIV infection, but also to reduce the risk of a major cause of death and morbidity in young children worldwide. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00197730.
OBJECTIVES: To identify risk factors, including maternal antiretroviral therapy (ART), for diarrhea in Tanzanian children exposed to HIV during the first 2 years of life. STUDY DESIGN: Using generalized estimating equations, we analyzed data from a cohort of 2387 Tanzanian children exposed to HIV from age 6 weeks to 2 years, as well as data from their mothers, to determine risk factors for diarrhea in children. Mothers recorded diarrhea in a diary and reported results at visits scheduled every four weeks. RESULTS: Body mass index was ≥18.5 in 95.6% of mothers. World Health Organization HIV stage was 1/2 for 1255 (87.8%) mothers. ART was received by 24.3% of mothers, most initiating ART during pregnancy. At baseline (6 weeks of age) 264 (11.3%) children were infected with HIV. In children whose mothers received ART, the relative risk of diarrhea in children was 0.79 (95% CI 0.68-0.92), after we adjusted for multiple factors, including child HIV status and exclusive breastfeeding duration. Exclusive breastfeeding (relative risk 0.67, 95% CI 0.56-0.80) also was protective. CONCLUSION: Our results provide additional support to increase ART coverage for all pregnant mothers, to control clinical HIV progression, reduce perinatal HIV infection, but also to reduce the risk of a major cause of death and morbidity in young children worldwide. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00197730.
Authors: William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant Journal: J Clin Invest Date: 2008-04 Impact factor: 14.808
Authors: Z A Bhutta; R E Black; K H Brown; J M Gardner; S Gore; A Hidayat; F Khatun; R Martorell; N X Ninh; M E Penny; J L Rosado; S K Roy; M Ruel; S Sazawal; A Shankar Journal: J Pediatr Date: 1999-12 Impact factor: 4.406
Authors: Ai Koyanagi; Jean H Humphrey; Robert Ntozini; Kusum Nathoo; Lawrence H Moulton; Peter Iliff; Kuda Mutasa; Andrea Ruff; Brian Ward Journal: Pediatr Infect Dis J Date: 2011-01 Impact factor: 2.129
Authors: William Checkley; Gillian Buckley; Robert H Gilman; Ana Mo Assis; Richard L Guerrant; Saul S Morris; Kåre Mølbak; Palle Valentiner-Branth; Claudio F Lanata; Robert E Black Journal: Int J Epidemiol Date: 2008-06-20 Impact factor: 7.196
Authors: Roger L Shapiro; Shahin Lockman; Soyeon Kim; Laura Smeaton; Jeremy T Rahkola; Ibou Thior; Carolyn Wester; Claire Moffat; Peter Arimi; Patrick Ndase; Aida Asmelash; Lisa Stevens; Monty Montano; Joseph Makhema; Max Essex; Edward N Janoff Journal: J Infect Dis Date: 2007-07-09 Impact factor: 5.226
Authors: Lindsey M Locks; Karim P Manji; Roland Kupka; Enju Liu; Rodrick Kisenge; Christine M McDonald; Said Aboud; Molin Wang; Wafaie W Fawzi; Christopher P Duggan Journal: J Pediatr Date: 2016-11-07 Impact factor: 4.406
Authors: Emily L Deichsel; Grace C John-Stewart; Judd L Walson; Dorothy Mbori-Ngacha; Barbra A Richardson; Brandon L Guthrie; Carey Farquhar; Rose Bosire; Patricia B Pavlinac Journal: PLoS One Date: 2020-07-27 Impact factor: 3.240
Authors: Emily L Deichsel; Patricia B Pavlinac; Dorothy Mbori-Ngacha; Judd L Walson; Elizabeth Maleche-Obimbo; Carey Farquhar; Rose Bosire; Grace C John-Stewart Journal: Am J Trop Med Hyg Date: 2020-05 Impact factor: 2.345